Legend Biotech Corp ADS (LEGN)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | PHARMACEUTICALS |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Ying Huang |
| Employees: | 1,070 |
| Web site: | legendbiotech.com |
|
2101 COTTONTAIL LANE, SOMERSET, NJ, 08873
732-317-5050
| |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Legend Biotech Corporation engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma. The company also has a portfolio of earlier-stage autologous product candidates, which are in Phase I clinical trials for gastric cancer and T cell lymphoma.
Please log in first to see chart